• Recruiting

NCT03858205: Low-Dose Radiotherapy in Treating Painful Bone Metastases in Multiple Myeloma Patients

Updated: May 26

NCT03858205: Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma


palliative-rt-myeloma

Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma


This phase II trial studies how well low-dose radiotherapy works in treating bone pain in patients with multiple myeloma that has spread to the bone. Radiation therapy uses high energy x-rays, gamma rays, neutrons, protons, or other sources to kill tumor cells and shrink tumors. Low-dose radiotherapy may be more convenient for patients and their families, may not interfere as much with the timing of chemotherapy, and may have less chance for short term or long-term side effects from the radiation.


Sponsor:

University of Southern California


Collaborator:

National Cancer Institute (NCI)

 

ClinicalTrials.gov Identifier: NCT03858205


Official Title: Phase II Multi-Institutional Study of Low-Dose (2Gy x 2) Palliative Radiotherapy in the Treatment of Symptomatic Bone Metastases From Multiple Myeloma

First Posted : February 28, 2019


Click here to see details on ClinicalTrials.gov

 

Other: Quality-of-Life Assessment

Other: Questionnaire Administration

Radiation: Radiation Therapy

 

Locations

United States, California

United States, Georgia

United States, Massachusetts

United States, Minnesota

United States, New York

United States, Pennsylvania



Posts Archive